Survival status of the surgical treatment of hilar cholangiocarcinoma patient
10.3969/j.issn.1009-9905.2017.07.011
- VernacularTitle:肝门部胆管癌外科治疗的生存状况研究
- Author:
chuan Qing XIAO
1
;
qiang Hong HU
;
jun Jia LI
;
Jun LI
;
qing Ji SHI
Author Information
1. 武警四川总队医院肝胆一外科 四川 乐山614000
- Keywords:
Hilar cholangiocarcinoma;
Survival status;
Radical resection
- From:
Chinese Journal of Current Advances in General Surgery
2017;20(7):543-545,548
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the survival status of the surgical treatment of hilar cholangiocarcinoma patient and related factors that influence long-term survival rate of patients.Methods:79 hilar cholangiocarcinoma patients in our hospital from June 2008 to March 2011 were selected and retrospectively analyzed,survival status of patients after 1,3,5 years was observed and recorded,clinic data was given simple factor and COX regression analysis.Results:From 79 hilar cholangiocarcinoma patients,there were 41 cases given surgical resection,38 cases given operative drainage,postoperative survival rate of all patients after 1,3,5 years were 49.37％ 、22.78％ 、7.59％,postoperative survival rate of patients with surgical resection after 1,3,5 years were 70.73％、36.59％ 、14.63％,postoperative survival rate of patients with operative drainage after 1,3,5 years were 26.32％、7.89％、0.00％.The difference of 5-year survival rate of patients with different pathological pattern,TNM stages,differentiated degree,surgical approach,excision method,lymphatic metastasis or not,different incisal edge had statistic significance (P ＜0.05).Mucinous carcinoma,TNM stages 1 ～ IV,operative drainage,palliative surgery,lymphatic metastasis were independent risk factors that influence survival status of hilar cholangiocarcinoma patients (P ＜ 0.05).Conclusion:The prognosis of surgical treatment of hilar cholangiocarcinoma patient is poor,mucinous carcinoma,TNM stages Ⅲ ～ IV,operative drainage,palliative surgery,lymphatic metastasis are independent risk factors that influence survival status of hilar cholangiocarcinoma patients.
